Innospec Inc.IOSPNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank14
3Y CAGR-4.4%
5Y CAGR+6.6%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-4.4%/yr
vs -3.1%/yr prior
5Y CAGR
+6.6%/yr
Recent deceleration
Acceleration
-1.3pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM10.12%-16.9%
202412.17%+18.1%
202310.31%-11.0%
202211.58%-0.7%
202111.66%+59.0%
20207.33%-46.2%
201913.63%+3.6%
201813.15%-10.5%
201714.68%-9.9%
201616.30%-